Cetera Advisor Networks LLC Mannkind Corp Transaction History

Cetera Advisor Networks LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$3.25 - $5.27 $3,770 - $6,113	-1,160 Reduced 9.98%	10,467 $47,000
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $652 - $910	167 Added 1.46%	11,627 $48,000
Q2 2023 Aug 09, 2023	BUY	$3.72 - $4.79 $42,631 - $54,893	11,460 New	11,460 $46,000
Q3 2020 Nov 13, 2020	SELL	$1.56 - $2.08 $10,077 - $13,436	-6,460 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.94 - $2.21 $6,072 - $14,276	6,460 New	6,460 $11,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.